Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy1-3

American Journal of Clinical Nutrition

Volumn 79, Issue 2, 2004, Pages 318-325

  Brooks, Jennifer D ^a   Ward, Wendy E ^a   Lewis, Jacqueline E ^b   Hilditch, John ^b   Nickell, Leslie ^b   Wong, Evelyn ^b   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

16 hydroxyestrone; 2 hydroxyestrone; Biochemical markers of bone metabolism; Estrogen metabolism; Flaxseed lignans; Postmenopausal women; Soy isoflavones

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; BIOCHEMICAL MARKER; ESTRADIOL; ESTRONE; ESTRONE SULFATE; PHYTOESTROGEN; PLACEBO; ESTROGEN; ISOFLAVONE DERIVATIVE; PLANT MEDICINAL PRODUCT;

ARTICLE; BLOOD SAMPLING; BONE CELL; CELL METABOLISM; CHEMICAL MODIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; ESTRADIOL BLOOD LEVEL; ESTROGEN EXCRETION; ESTROGEN METABOLISM; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; LINSEED; MENOPAUSAL SYNDROME; METABOLITE; OBSERVATION; SEX HORMONE DETERMINATION; SOYBEAN; URINALYSIS; URINARY EXCRETION; BLOOD; BONE; DOUBLE BLIND PROCEDURE; FLAX; METABOLISM; MIDDLE AGED; PLANT SEED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; URINE;

BONE AND BONES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTROGENS; FEMALE; FLAX; HUMANS; ISOFLAVONES; MIDDLE AGED; PHYTOESTROGENS; PLANT PREPARATIONS; POSTMENOPAUSE; SEEDS; SOYBEANS;

EID: 1342286100     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.2.318     Document Type: Article

References (62)

1. Thompson LU. Role of lignans in carcinogenesis. In: Romeo J, ed. Recent advances in phytochemistry. Vol 33. Phytochemicals in human health protection, nutrition, and plant defense. New York: Plenum Publishers, 1999:51-65.
2. Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997;17:353-81.
3. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001;39:58-65.
4. Le Bail J, Champaveir Y, Chulia A, Habrioux G. Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. Life Sci 2000;66:1281-91.
5. Welshons W, Murphy C, Koch R, Calaf G, Jordan V. Stimulation of breast cancer cell lines in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 1987;10:169-75.
6. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002;62:2474-7.
7. Lottering M, Haag M, Seeger J. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 1992;52:5926-32.
8. Dowsett M, Detre S, Rowlands M, Grimshaw R. Oestrogen formation in breast: clinical and biological importance. J Endocrinol 1996;150(suppl):S59-63.
9. Rickard DJ, Subramaniam M, Spelsberg TC. Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem 1999;32-33(suppl):123-32.
10. McCauley LK, Tozum TF, Rosol TJ. Estrogen receptors in skeletal metabolism: lessons from genetically modified models of receptor function. Crit Rev Eukaryot Gene Expr 2002;12:89-100.
11. Michnovicz J, Rosenberg D. Oxidative metabolism of estrogens in rat intestinal mitochondria. Biochem Pharmacol 1992;43:1847-52.
12. Lippert C, Seeger H, Mueck AO, Lippert TH. The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells. Life Sci 2000;67:1653-8.
13. Niwa T, Bradlow HL, Fishman J, Swaneck GE. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture. Steroids 1990;55:297-302.
14. Kuller LH, Matthews KA, Meilahn EN. Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis. J Steroid Biochem Mol Biol 2000;74:297-309.
15. Zhu B, Conney A. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
16. Schneider J, Kinne D, Fracchia A, et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A 1982;79:3047-51.
17. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-Hy-droxyestrone: the 'good' estrogen. J Endocrinol 1996;150(suppl):S259-65.
18. Gupta M, McDougal A, Safe S. Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 1998;67:413-9.
19. Telang N, Suto A, Wong W, Osborne P, Bradlow H. Induction by estrogen metabolite 16β-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-8.
20. Fishman J, Martucci C. Biological properties of 16β-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 1980;51:611-5.
21. Lotinun S, Westerlind K, Turner R. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovarectomized growing rats. J Endocrinol 2001;170:165-74.
22. Osborne M, Bradlow H, Wong G, Telang N. Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 1993;85:1917-20.
23. Fowke J, Longcope C, Hebert J. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:773-9.
24. Westerlind KC, Gibson KJ, Malone P, Evans GL, Turner RT. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J Bone Miner Res 1998;13:1023-31.
25. Lim SK, Won YJ, Lee JH, et al: Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 1997;82:1001-6.
26. Lu L, Cree M, Josyula S, Nagamani M, Grady J, Anderson K. Increased urinary excretion of 2-hydroxyestrone but not 16α-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res 2000;60:1299-305.
27. Xu X, Duncan A, Merz B, Kurzer M. Effects of soy isoflavones and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:1101-8.
28. Haggans C, Hutchins A, Olson B, Thomas W, Martini M, Slavin J. Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr Cancer 1999;33:188-95.
29. Lu L, Anderson K, Grady J, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000;60:4112-21.
30. Adlercreutz H, Bannwart C, Wähälä K, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993;44:147-53.
31. Wang C, Mäkelä T, Hase T, Adlercreutz H, Kurzer M. Lignans and flavonoids inhibit aromatase enzyme in human preadicpocytes. J Steroid Biochem Mol Biol 1994;50:205-12.
32. Evans B, Griffiths K, Morton M. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
33. Gunnarsson C, Olsson B, Stål O, et al. Abnormal expression of 17β-HSD in breast cancer predicts late recurrence. Cancer Res 2001;61:8448-51.
34. Peltoketo H, Isomaa V, Poutanen M, Vihko R. Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type I. J Endocrinol 1996;150(suppl):S21- 30.
35. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002;87:1527-32.
36. Persky VW, Turyk ME, Wang L, et al. Effect of soy protein on endogenous hormones in postmenopausal women. Am J Clin Nutr 2002;75:145-53.
37. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl):1375S-9S.
38. Wangen KE, Duncan AM, Merz-Demlow BE, et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000;85:3043-8.
39. Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 2002;94:1166-74.
40. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:195-201.
41. Lubin F, Ruder A, Wax Y, Modan B. Overweight and changes in weight throughout adult life in breast cancer etiology. A case control study. Am J Epidemiol 1985;122:579-88.
42. Toniolo P, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
43. Haggans CJ, Travelli EJ, Thomas W, Martini MC, Slavin JL. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:719-25.
44. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HH, Thompson LU. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 1996;126:2012-9.
45. Klug T, Bradlow L, Sepkovic D. Monoclonal antibody-based enzyme immunoassay for simultaneous quantification of 2- and 16α-hydroxyestrone in urine. Steroids 1994;59:648-55.
46. Xu X, Duncan A, Wangen K, Kurzer M. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:781-6.
47. Kurzer M. Hormonal effects of soy isoflavones: studies in premenopausal and postmenopausal women. J Nutr 2000;130:6605-1S.
48. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94.
49. Martini M, Dancisak B, Haggans C, Thomas W, Slavin J. Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr Cancer 1999;34:133-9.
50. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 2002;13:200-4.
51. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-21.
52. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-52.
53. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-6.
54. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 2000;11:721-4.
55. Adlercreutz H, Heikkinen R, Woods M, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;2:1295-8.
56. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:3479-84.
57. Cunnane S, Ganguli S, Menard C, et al. High alpha-linolenic acid (Linun usitatissimum): some nutritional properties in humans. Br J Nutr 1993;69:443-53.
58. Thompson L, Rickard S, Orcheson L, Seidl M. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996;17:1373-6.
59. Chajes V, Sattler W, Stranzl A, Kostner G. Influence of n - 3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin E. Breast Cancer Res Treat 1995;34:199-212.
60. Jefcoate C, Liehr J, Santen R, et al. Tissue specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 2000;27:95-111.
61. Pasqualini J, Chetrite G. Paradoxical effect of estradiol: it can block its own biotransformation in human breast cancer cells. J Steroid Biochem Mol Biol 2001;78:21-4.
62. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.